Administrative/Regulatory
Nov. 17, 2016
Drug price initiative was a surprise loss on election night
California has come closer than any other state to implementing price controls on drug products, but voters nevertheless rejected Proposition 61. By Judith A. Waltz and Jason L. Drori
Donald Trump was not the only surprise winner on election night last week. In a reversal of statewide polling, California voters defeated a ballot initiative known as the California Drug Price Relief Act, or Proposition 61. The defeat comes at a time of laser-like focus on the pricing and affordability of pharmaceutical products, with Mylan's Epi-Pen emergency allergy injection the latest in a string of high...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In